BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19008315)

  • 21. Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell lines.
    Sommer A; Hoffmann J; Lichtner RB; Schneider MR; Parczyk K
    J Steroid Biochem Mol Biol; 2003 May; 85(1):33-47. PubMed ID: 12798355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways.
    Mancuso M; Leonardi S; Giardullo P; Pasquali E; Borra F; Stefano ID; Prisco MG; Tanori M; Scambia G; Majo VD; Pazzaglia S; Saran A; Gallo D
    Cancer Lett; 2011 Sep; 308(2):197-202. PubMed ID: 21636213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen alleviates acetic acid-induced gastric or colonic damage via both ERα- and ERβ-mediated and direct antioxidant mechanisms in rats.
    Kumral ZN; Memi G; Ercan F; Yeğen BC
    Inflammation; 2014 Jun; 37(3):694-705. PubMed ID: 24323397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of estrogen receptor α and β on the expression of visfatin and retinol-binding protein 4 in 3T3-L1 adipocytes.
    Jung US; Jeong KJ; Kang JK; Yi K; Shin JH; Seo HS; Kim T; Kim SH; Hur JY
    Int J Mol Med; 2013 Sep; 32(3):723-8. PubMed ID: 23857051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen regulation of bone growth and endocrine function in the ovariectomized rat: discrimination of responses involving estrogen receptor α/estrogen receptor β, G protein-coupled estrogen receptor, or estrogen-related receptor γ using fulvestrant (ICI 182780).
    Fitts JM; Klein RM; Powers CA
    J Pharmacol Exp Ther; 2011 Jul; 338(1):246-54. PubMed ID: 21464335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender-specific protection of estrogen against gastric acid-induced duodenal injury: stimulation of duodenal mucosal bicarbonate secretion.
    Smith A; Contreras C; Ko KH; Chow J; Dong X; Tuo B; Zhang HH; Chen DB; Dong H
    Endocrinology; 2008 Sep; 149(9):4554-66. PubMed ID: 18499763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J; Sui M; Fan W
    Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of estrogen receptor beta expression in Chinese hamster ovary (CHO) cells and comparison of estrogen-responsive gene transcription in cells adapted to serum-free media.
    Thomas PB; Risinger KE; Klinge CM
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):41-55. PubMed ID: 12943744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASC deficiency suppresses proliferation and prevents medulloblastoma incidence.
    Knight ER; Patel EY; Flowers CA; Crowther AJ; Ting JP; Miller CR; Gershon TR; Deshmukh M
    Oncogene; 2015 Jan; 34(3):394-402. PubMed ID: 24469054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen directly respresses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons.
    Roy D; Angelini NL; Belsham DD
    Endocrinology; 1999 Nov; 140(11):5045-53. PubMed ID: 10537130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.
    Garcia I; Crowther AJ; Gama V; Miller CR; Deshmukh M; Gershon TR
    Oncogene; 2013 May; 32(18):2304-14. PubMed ID: 22710714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma.
    Huq S; Kannapadi NV; Casaos J; Lott T; Felder R; Serra R; Gorelick NL; Ruiz-Cardozo MA; Ding AS; Cecia A; Medikonda R; Ehresman J; Brem H; Skuli N; Tyler BM
    J Neurosurg Pediatr; 2021 Feb; 27(4):482-488. PubMed ID: 33545678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor α and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models.
    Gingerich S; Kim GL; Chalmers JA; Koletar MM; Wang X; Wang Y; Belsham DD
    Neuroscience; 2010 Sep; 170(1):54-66. PubMed ID: 20619320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
    Barkhem T; Carlsson B; Nilsson Y; Enmark E; Gustafsson J; Nilsson S
    Mol Pharmacol; 1998 Jul; 54(1):105-12. PubMed ID: 9658195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
    Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
    Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
    Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels.
    Yoneya T; Tsunenari T; Taniguchi K; Kanbe Y; Morikawa K; Yamada-Okabe H; Lee YH; Lee MH; Kwon LS
    Oncol Rep; 2009 Mar; 21(3):747-55. PubMed ID: 19212635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.